u/Comfortable-Bug-8442

BHF trading at $62.57, $7.43 below the $70 all-cash Aquarian deal price. Just reported Q1 with adjusted earnings of $4.35/share (beat) and RBC ratio 430-450% (strong). Shareholder vote passed back in February. Deal expected to close 2026 pending regulatory approvals.

Here's what my analysis tool shows:

**The Spread Opportunity**

Current: $62.57 → Deal: $70.00 (11.9% upside)

This isn't about fundamentals—it's pure merger arb. The acquisition price is contractually fixed.

**Quick Fundamentals Check**

- Solid capital position (RBC upper end of target)

- Annuity sales $2.2B (down QoQ but stable)

- Life segment struggling a bit

- Holding co liquidity $0.9B

**Remaining Hurdles**

1. HSR antitrust clearance
2. State insurance approvals
3. FINRA (broker-dealer side)

No major red flags in earnings that would trigger MAC clause.

**Risks if Deal Breaks**

Stock likely drops to ~$48-50 range (20% downside). Termination fee to BHF but that's cold comfort.

**Why the Spread?**

Post-earnings reaction muted. Market's discounting regulatory risk more than I think is warranted given clean shareholder vote + solid capital position.

AIG's Q1 looked pretty good to me, but the stock did not seem to react much. The company appears to be making money on its insurance policies, returns look decent, premiums are growing, and management is still buying back stock and raising the dividend. The valuation also does not look crazy to me, around a low-teens earnings multiple and close to book value depending on the source. I know insurance companies can be hard to judge because storms, claims, investments, and accounting details can change the picture fast. But if the core business is really improving, I am wondering why the market is not giving it more credit. For people who follow insurers, is this just a boring stock doing fine, or is there a risk here that I am missing?

Medallion Financial reported Q1 2026, and at first glance the operating numbers looked better than the after-hours move suggested:

• net interest income up 5% to $54.1M
• loan originations up 34% to $376.9M
• total loans now at $2.618B, up 5% YoY
• book value per share $17.10 vs $16.36 last year
• next quarterly dividend raised to $0.14 from $0.12

EPS came in at $0.20 vs $0.50 a year ago, but most of that gap is because last year had a $9.4M equity-investment gain vs only $0.3M this quarter — so the YoY net income comp seems noisy rather than a real drop in the lending business.

Stock still traded down after hours.

For people who follow small specialty finance / lenders: is the market reading something real here — credit quality, funding costs, NIM, provisioning, guidance — or is this just a small-cap getting sold on a weaker headline EPS without looking deeper?